bpc-157 clinical trials human safety – No Proof Required! | Office for Science and Society Regeneration or Risk? A Narrative

4 wks @ 250 mcg/day: ~1 vial (20 mg) 4 wks @ 500 mcg/day: ~1 vial (20 mg), leftover On 10 mg vials: roughly double the vial count Insulin Syringes (U-100, 1 mL) Per injection: 1 syringe 4 weeks (once daily): ~28 syringes 8 weeks (once daily): ~56 syringes Bacteriostatic Water (10 mL bottles) Use ~3.0 mL per blend vial for reconstitution

Immediate Absorption: Intramuscular or subcutaneous administration delivers quick correction of B12 deficiency and maximum bioavailability

A doctor or trained nurse decides the route and site based on the patient's condition and treatment needs

doi: 10.1186/1471-2164-9-75

BPC-157: Stomach Protective Compound

Central Kansas Podiatry Associates provides complete and customized care for patients of all ages